Related Experiment Video
Updated: Aug 6, 2026

The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation
Published on: August 15, 2018
[Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate]
S Ducrocq1, V Biran-Mucignat, P-Y Boelle
1Service de Néonatologie, Hôpital d'Enfants Armand-Trousseau, APHP, 26, avenue du Docteur-Arnold-Netter, 75771 Paris cedex 12, France. sarah.ducrocq@cch.aphp.fr <sarah.ducrocq@cch.aphp.fr>
Insights
Persistent apnea in preterm infants can be predicted by factors like low birth weight and reflux. Discharging infants home with caffeine citrate treatment is a safe alternative to prolonged hospitalization.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
Background:
- Apnea of prematurity typically resolves by 36-37 weeks postmenstrual age.
- Persistent apnea beyond term affects infants born at the youngest gestational ages (24-28 weeks).
- Caffeine citrate treatment is used for preterm infants with persistent apnea, with discontinuation typically at 42 weeks postmenstrual age.
Purpose of the Study:
- To identify predictive factors for persistent apnea in preterm infants.
- To evaluate the safety and efficacy of home-based caffeine citrate treatment.
Main Methods:
- Retrospective study comparing 41 preterm infants discharged with treatment to 123 discharged without.
- Analysis of clinical factors associated with persistent apnea.
Main Results:
- Significant predictors of persistent apnea include birth weight <1500 g, hypotension, gastroesophageal reflux, need for continuous positive airway pressure, and multiparity.
- No infant deaths or adverse effects were reported by parents during home treatment.
Conclusions:
- Persistent apnea can lead to extended hospital stays.
- Identifiable risk factors aid in managing persistent apnea.
- Home discharge with caffeine citrate treatment is a viable alternative to hospitalization for selected preterm infants.
Introduction:
Apnea of prematurity develop during the first days of life and usually resolve by the time the infant reaches 36-37 weeks postmenstrual age. In a few cases, they persist beyond term, especially in infants delivered at the youngest gestational ages (24-28 GA), and require specific care. In our unit, those preterm babies are discharged home with caffeine citrate treatment. Discontinuing the treatment is performed in hospital when they achieve a postmenstrual age of at least 42 weeks.
Objective:
To identify predictive factors of persistent apnea in preterm babies.
Material And Methods:
Retrospective study comparing a population of 41 preterm infants discharged with treatment to 123 preterm babies discharged without treatment to identify predictors of persistent apnea.
Results:
Factors significantly associated were: birth weight<1500 g, initial hypotension, gastroesophageal reflux, need for continuous positive airway pressure and multiparity. At home, no infant died and no adverse effect was reported by parents.
Conclusion:
Persistent apnea can be responsible for prolonged hospitalization. Risk factors can be identified in some children. Discharging with treatment can be an alternative to their hospitalization.
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Sleep Apnea
The condition is more prevalent among...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Endotracheal Tube Extubation
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals.
Acute Respiratory Failure-III
Breathing
